切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - DREADD Ligands - NTRK1/TRKA - Flk1 - Sir2-like Family Deacetylases (Sirtuins)

10 件产品

每页
清除全部
  1. Inauhzin
    B3272 Inauhzin
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT1抑制剂
      ≥23.5 mg/mL
      insoluble in H2O
  2. Midostaurin (PKC412)
    B3709 Midostaurin (PKC412)
    中文名: 米哚妥林
    Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinB
    Summary: PKC抑制剂
      ≥57.1 mg/mL
      insoluble in H2O
  3. Tenovin-6
    A8302 Tenovin-6
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT抑制剂,p53激活剂
      ≥22.75 mg/mL
      insoluble in H2O
  4. Brivanib (BMS-540215)
    A2597 Brivanib (BMS-540215)
    中文名: 布立尼布
    Target: VEGFR|FGFR|Flk1
    Summary: VEGFR-2的ATP竞争性抑制剂
      ≥18.5 mg/mL
      insoluble in H2O
  5. SRT2104 (GSK2245840)
    A3821 SRT2104 (GSK2245840)
     1 Citation
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT1激活剂
      ≥6.46 mg/mL
      insoluble in H2O
  6. Clozapine N-oxide(CNO)
    A3317 Clozapine N-oxide(CNO)
     1 Citation
    中文名: 氯氮平的N-氧化物
    Target: DREADD Ligands
    Summary: Clozapine代谢产物,用于化学遗传学
      ≥17.15 mg/mL
      ≥49 mg/mL
  7. Tenovin-1
    A4203 Tenovin-1
    Target: Sir2-like Family Deacetylases (Sirtuins)|p53|p21
    Summary: SIRT2 抑制剂,p53激活剂
      ≥15 mg/mL
      insoluble in H2O
  8. ENMD-2076
    A4130 ENMD-2076
    Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-Fms
    Summary: Aurora A/Flt3的选择性抑制剂
      ≥18.75 mg/mL
      insoluble in H2O
  9. Resveratrol
    A4182 Resveratrol
     2 Citation
    中文名: 白藜芦醇
    Target: Sir2-like Family Deacetylases (Sirtuins)|COX|LOX|Adenylyl cyclase|Quinone reductase
    Summary: SIRT1激活剂
      ≥9.65 mg/mL
      insoluble in H2O
  10. SRT1720 HCl
    A4180 SRT1720 HCl
     3 Citation
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT1激活剂
      ≥25.3 mg/mL
      ≥15.37 mg/mL

10 件产品

每页